查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1703395

乳房病變定位方法市場－全球產業規模、佔有率、趨勢、機會和預測（按類型、地區和競爭細分，2020-2030 年）

Breast Lesion Localization Methods Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球乳房病變定位方法市值為 7.6426 億美元，預計到 2030 年將達到 10.7378 億美元，預測期內年複合成長率(CAGR) 為 6.03%。受全球乳癌發病率上升以及對精確診斷和手術干預方法的需求不斷增加的推動，該市場正在經歷強勁成長。

市場概覽
預測期 2026-2030
2024年市場規模 7.6426億美元
2030年市場規模 10.7378億美元
2025-2030 年複合年成長率 6.03%
成長最快的領域 放射性同位素定位
最大的市場 北美洲

乳房病變定位技術在幫助放射科醫生和外科醫生在乳房保留手術或活體組織切片期間準確識別和切除異常組織方面發揮關鍵作用。這些方法對於保存健康組織同時確保有效治療惡性或可疑病變至關重要。

主要成長動力之一是人們對早期乳癌檢測認知的提高，這得益於篩檢計畫的廣泛實施。由於乳癌仍然是全球女性中最常見的癌症之一，早期診斷對於提高存活率和治療效果至關重要。因此，人們越來越重視開發先進且高度可靠的定位技術，以提高手術精度、最大限度地降低再次手術的風險並提高整體臨床成功率。

然而，先進本地化技術的高成本以及專業培訓的需求可能會阻礙市場擴張。這些因素構成了障礙，尤其是在中低收入國家。此外，不同地區監管的複雜性和不一致的報銷框架可能會限制某些市場的採用。

關鍵市場促進因素

全球醫療保健產業的擴張

主要市場挑戰

發展中市場的可近性有限

主要市場趨勢

重視早期檢測與技術創新

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球乳房病變定位方法市場的影響

第5章：全球乳房病變定位方法市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依類型（放射性同位素定位、無線電導引隱匿性病變定位 (ROLL)、放射性種子定位 (RSL)、磁示蹤劑、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美乳房病變定位方法市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲乳房病變定位方法市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太乳房病變定位方法市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美洲乳房病變定位方法市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲乳房病變定位方法市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第13章：全球乳房病變定位方法市場：SWOT分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Becton, Dickinson and Company
  • SOMATEX Medical Technologies GmbH
  • Argon Medical Devices, Inc.
  • Merit Medical Systems, Inc.
  • Cook Group Incorporated
  • STERYLAB Srl
  • Theragenics Corporation
  • Mdl Srl
  • Stryker Corporation

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 28078

Global breast lesion localization methods market was valued at USD 764.26 million in 2024 and is projected to reach USD 1,073.78 million by 2030, growing at a compound annual growth rate (CAGR) of 6.03% during the forecast period. This market is witnessing robust growth, driven by the rising global incidence of breast cancer and the increasing demand for accurate diagnostic and surgical intervention methods.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 764.26 Million
Market Size 2030USD 1073.78 Million
CAGR 2025-20306.03%
Fastest Growing SegmentRadioisotope Localization
Largest MarketNorth America

Breast lesion localization techniques play a critical role in enabling radiologists and surgeons to accurately identify and remove abnormal tissue during breast-conserving surgeries or biopsies. These methods are vital for preserving healthy tissue while ensuring the effective treatment of malignant or suspicious lesions.

One of the principal growth drivers is the heightened awareness of early breast cancer detection, supported by the widespread implementation of screening programs. As breast cancer continues to be one of the most prevalent cancers among women worldwide, early diagnosis is essential to improving survival rates and treatment outcomes. Consequently, there is a growing emphasis on developing advanced and highly reliable localization techniques that enhance surgical precision, minimize the risk of reoperation, and improve overall clinical success.

However, market expansion may be hindered by the high cost of advanced localization technologies and the need for specialized training. These factors pose barriers, particularly in low- and middle-income countries. In addition, regulatory complexities and inconsistent reimbursement frameworks across regions may limit adoption in certain markets.

Key Market Drivers

Expansion of the Global Healthcare Sector

The continued growth of the global healthcare industry is a major catalyst for the breast lesion localization methods market. Global healthcare expenditures now exceed USD 4 trillion annually, with pharmaceuticals and biotechnology accounting for approximately USD 850 billion, and medical technology and diagnostics contributing more than USD 400 billion. With rapid advancements in medical technologies and a stronger focus on early cancer detection, healthcare systems are increasingly investing in sophisticated localization solutions.

These technologies are especially critical for detecting and removing non-palpable breast lesions, ensuring more accurate surgical interventions. The growing incidence of breast cancer is a significant factor supporting this trend. According to the World Health Organization (WHO), breast cancer was responsible for 670,000 deaths globally in 2022. Notably, nearly half of all diagnosed cases occur in women without known risk factors other than age and gender. Additionally, approximately 0.5-1% of breast cancer cases are diagnosed in men.

As healthcare providers enhance screening initiatives and early detection strategies, there is a corresponding increase in the identification of breast lesions requiring pre-surgical localization. Advanced techniques such as wire-guided localization (WGL), radioactive seed localization (RSL), and magnetic seed localization are becoming essential tools in ensuring surgical accuracy and reducing the likelihood of complications or repeat procedures.

Key Market Challenges

Limited Accessibility in Developing Markets

One of the key obstacles facing the breast lesion localization methods market is the restricted availability of advanced technologies in developing regions. While high-income countries have made substantial progress in breast cancer screening and diagnostic infrastructure, many low- and middle-income regions continue to face limited access to modern localization methods.

This disparity impacts the quality of patient care and poses challenges to early diagnosis and effective treatment. Contributing factors include inadequate healthcare infrastructure, limited access to advanced equipment, and a shortage of trained professionals. Many facilities in these regions still rely on traditional methods, such as wire localization, which, while functional, offer lower precision and carry a higher risk of surgical complications and reoperations.

Key Market Trends

Emphasis on Early Detection and Technological Innovation

A prominent trend shaping the breast lesion localization methods market is the increasing prioritization of early breast cancer detection. Digital mammography-recognized for its high specificity and sensitivity (exceeding 90%)-continues to be the cornerstone of breast cancer screening across high-income countries. These efforts are yielding earlier diagnoses and improving survival outcomes.

As global healthcare systems strive to detect cancer at its earliest, most treatable stages, the demand for advanced lesion localization technologies is growing. Early-stage lesions, which are often small and non-palpable, necessitate precise localization to facilitate accurate surgical removal. This requirement is accelerating the adoption of cutting-edge localization techniques, including wire-guided, radioactive seed, and magnetic seed localization.

These technologies are helping redefine breast cancer management by enabling more effective surgical planning, reducing the likelihood of reoperation, and enhancing patient outcomes. As the emphasis on early intervention intensifies, the market is poised to benefit from the increased integration of innovative, image-guided localization methods into clinical workflows.

Key Market Players

  • Becton, Dickinson and Company
  • SOMATEX Medical Technologies GmbH
  • Argon Medical Devices, Inc.
  • Merit Medical Systems, Inc.
  • Cook Group Incorporated
  • STERYLAB S.r.l.
  • Theragenics Corporation
  • Mdl Srl
  • Stryker Corporation

Report Scope

In this report, the Global Breast Lesion Localization Methods Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Breast Lesion Localization Methods Market, By Type:

  • Radioisotope Localization
  • Radio Guided Occult-Lesion Localization (ROLL)
  • Radioactive-Seed Localization (RSL)
  • Magnetic Tracer
  • Others

Breast Lesion Localization Methods Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Breast Lesion Localization Methods Market.

Available Customizations:

Global Breast Lesion Localization Methods Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Breast Lesion Localization Methods Market

5. Global Breast Lesion Localization Methods Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Radioisotope Localization, Radio Guided Occult-Lesion Localization (ROLL), Radioactive-Seed Localization (RSL), Magnetic Tracer, Others)
    • 5.2.2. By Region
    • 5.2.3. By Company (2024)
  • 5.3. Market Map

6. North America Breast Lesion Localization Methods Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Breast Lesion Localization Methods Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
    • 6.3.2. Mexico Breast Lesion Localization Methods Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
    • 6.3.3. Canada Breast Lesion Localization Methods Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type

7. Europe Breast Lesion Localization Methods Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Breast Lesion Localization Methods Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
    • 7.3.2. Germany Breast Lesion Localization Methods Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
    • 7.3.3. United Kingdom Breast Lesion Localization Methods Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
    • 7.3.4. Italy Breast Lesion Localization Methods Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
    • 7.3.5. Spain Breast Lesion Localization Methods Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type

8. Asia Pacific Breast Lesion Localization Methods Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Breast Lesion Localization Methods Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
    • 8.3.2. India Breast Lesion Localization Methods Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
    • 8.3.3. South Korea Breast Lesion Localization Methods Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
    • 8.3.4. Japan Breast Lesion Localization Methods Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
    • 8.3.5. Australia Breast Lesion Localization Methods Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type

9. South America Breast Lesion Localization Methods Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Breast Lesion Localization Methods Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
    • 9.3.2. Argentina Breast Lesion Localization Methods Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
    • 9.3.3. Colombia Breast Lesion Localization Methods Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type

10. Middle East and Africa Breast Lesion Localization Methods Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Breast Lesion Localization Methods Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
    • 10.3.2. Saudi Arabia Breast Lesion Localization Methods Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
    • 10.3.3. UAE Breast Lesion Localization Methods Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Breast Lesion Localization Methods Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Becton, Dickinson and Company
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. SOMATEX Medical Technologies GmbH
  • 15.3. Argon Medical Devices, Inc.
  • 15.4. Merit Medical Systems, Inc.
  • 15.5. Cook Group Incorporated
  • 15.6. STERYLAB S.r.l.
  • 15.7. Theragenics Corporation
  • 15.8. Mdl Srl
  • 15.9. Stryker Corporation

16. Strategic Recommendations

17. About Us & Disclaimer